NOV 03, 2017 03:00 PM PDT

Scientists Find a Cancer Kryptonite in Meteors

WRITTEN BY: Xuan Pham

Image credit: Pixabay.com

A dense metal found in space rocks could be the kryptonite for cancer cells, researchers announced.

The metal is known as iridium, and holds the title of second most dense metal on earth (after osmium).  While it’s found within the Earth’s crust, iridium is many times more abundant in meteorites (space rocks that enters and survives a landing through the Earth’s atmosphere). The metal is named after the Greek goddess of the rainbow, Iris, because salts from this metal take on a brilliant luminescence.

Aside from hues and density, iridium is known for its high melting point, hardness, and ability to resist corrosion. These properties made the metal attractive for many types of industrial applications. Furthermore, the radioactive isotope of this metal is used in one form of cancer radiotherapy.

Taking the medical applications of iridium even further, researchers from the University of Warwick, in collaboration with a team from Sun Yat-Sen University in China, created a new iridium-based weapon targeted at cancer cells.

The team took iridium and paired it with an organic material. Activated with light, the resulting product forces the oxygen molecules in cancer cells to take on a poisonous form. Specifically, normal oxygen molecules existing as a doublet (O2) would turn into a singlet (O), which is lethal to the cells.

In the lab, the team tested the effect of the organic-iridium compound against a model of a lung tumor sphere. Once activated by a red laser, the light-reactive coating on the compound went to work, and the oxygen molecules in the cancer cells were slowly converted into singlets. This effect was observed in every layer of the tumor sphere – a testament to the potency of this therapy.

Importantly, the team showed the organic-iridium compound seemed to have no effect on healthy cells.

"This project is a leap forward in understanding how these new iridium-based anti-cancer compounds are attacking cancer cells, introducing different mechanisms of action, to get around the resistance issue and tackle cancer from a different angle,” said Cookson Chiu, one of the study’s co-authors.

Iridium is part of the platinum group, and platinum itself plays a big role in a variety of cancer chemotherapies. “The potential of other precious metals such as iridium to provide new targeted drugs which attack cancer cells in completely new ways and combat resistance, and which can be used safely with the minimum of side-effects, is now being explored,” said Peter Sadler, the study’s senior author.

Because the metal is much more abundant in asteroids and meteors, some scientists hypothesized that the iridium found on Earth may have been of extraterrestrial origins. Specifically, some speculate that Earth’s iridium supply originated from the asteroid that killed the dinosaurs.    

“It's certainly now time to try to make good medical use of the iridium delivered to us by an asteroid 66 million years ago!" said Peter O'Connor, Professor of Analytical Chemistry at Warwick, and one of the study authors.

One thing is for sure, if iridium can be successfully applied against human cancers, no other metals or compounds could rival its story of origin.

Additional sources: University of Warwick

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUL 17, 2018
Cancer
JUL 17, 2018
Immunotherapy Diversification: From CAR-T cells to CAR-NK cells
New advances have made it possible for immunotherapy researchers to use natural killer cells, which are our body's normal defense for cancerous cells, to target tumors....
AUG 14, 2018
Cancer
AUG 14, 2018
New Drug for Refractory Cutaneous T-cell Lymphoma
Mogamulizumab was approved by the FDA this month after a very successful Phase III clinical trial demonstrating its effectiveness in treating patients with challenging CTCL....
AUG 26, 2018
Cancer
AUG 26, 2018
Can antireflux surgery prevent Esophageal cancer?
Heartburn or gastroesophageal reflux disease (GERD) is a widespread health problem affecting 10 to 20% of adults in Western populations. If GERD left untre...
AUG 30, 2018
Genetics & Genomics
AUG 30, 2018
Genetic Changes can Help Diagnose Childhood Cancers Far Earlier
New research has revealed genetic rearrangements that happen far before bone cancer starts growing in children....
SEP 06, 2018
Microbiology
SEP 06, 2018
The Oncomicrobiome - Linking Microbes and Cancer
Scientists want to know more about how the microbes we carry in and on us are related to cancer development....
NOV 20, 2018
Cell & Molecular Biology
NOV 20, 2018
A Warning About Using Epigenetic Modifiers as Therapeutic Targets
In the long run, some cancer therapeutics may be doing more harm than good....
Loading Comments...